REPLENINE-VF

This brand name is authorized in Cyprus, Israel, Malta, Singapore, United Kingdom

Active ingredients

The drug REPLENINE-VF contains one active pharmaceutical ingredient (API):

1 Human plasma coagulation factor IX concentrate UNII 6U90Y1795T - COAGULATION FACTOR IX HUMAN

Factor IX is a single chain glycoprotein with a molecular mass of about 68,000 Dalton. It is a vitamin-K dependent coagulation factor and it is synthesised in the liver. Factor IX is activated by factor XIa in the intrinsic coagulation pathway and by the factor VII/tissue factor complex in the extrinsic pathway. Activated factor IX, in combination with activated factor VIII, activates factor X. Read about Coagulation factor IX

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B02BD04	Coagulation factor IX	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 97963, 97964
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6894
Country: MT	Medicines Authority	Identifier(s): MA1320/00301
Country: SG	Health Sciences Authority	Identifier(s): 08984P